Blog Archives

Adyen NV (ADYEY-OTC, $8.47 US). An EBITDA Decline Does Not Equate to a Change in my Investment Thesis.

(EU converted to USD at the rate of 1.0868 as of 06/30/2023). Adyen NV, the fast growing publicly traded payment processor, reported a very disappointing first half 2023 fiscal result. Net revenues, at $803.2 million US, increased by 4.4% as

Posted in Open Blog

Novo Nordisk (NVO-NYSE, $187.57) and Eli Lilly (LLY-NYSE, $517.53) Seek to Potentially Upend Modern Preventative Healthcare. There Will be Winners and Losers.

A key study, detailed today, published by Novo Nordisk, confirm what has been widely assumed by medical researchers in the rather new GLP-1 medication class; that in addition to providing quantifiable and fairly immediate benefits for those with type 2

Posted in Open Blog

Grupo Comercial Chedraui (CHDRAUIB-MX, $5.72) Reports for Q2, 2023.

All figures reported in USD at the exchange rate of $.0585 US per Peso. Forex has served to obscure the US dollar revenue growth rate of Chedraui in Q2. Grupo Chedraui, a fast growing operator of supermarkets and warehouse clubs,

Posted in Open Blog

Grupo Chedraui (CHEDRAUI.B-MX-$5.68). Proposed Rancho Cucamonga Distribution Center Offers Insight on Chedraui USA Growth Ambitions.

The announcement by Grupo Chedraui concerning a new 1.4 million square foot distribution facility lease is a key clue in the next phase of organic growth for Chedraui USA, one perhaps overlooked by many. In May, Chedraui confirmed the beginning

Posted in Open Blog

Gnostic Global Large Cap Portfolio Return for the Fiscal Quarter Ended June 30th, 2023.

For the quarter ended June 30th, 2023, the major indexes performed as follows: 1. The DJIA rose by 3.4% 2. The S&P 500 rose by 8.3%. 3. the NASDAQ composite advanced by 12.8%. In comparison, the Gnostic Global portfolio advanced

Posted in Open Blog
Recent Comments